East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more East Resources Acquisition Charts. Click Here for more East Resources Acquisition Charts.](/p.php?pid=staticchart&s=N%5EERES&p=8&t=15)
eResearchTechnology, Inc. to Announce Fourth Quarter and 2004
Year End Results on February 9, 2005
PHILADELPHIA, Jan. 31 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc.
(eRT), (NASDAQ:ERES), a leading provider of centralized electrocardiographic
(ECG) collection and interpretation services, announced today that it will
release its fourth quarter and 2004 year end results for the period ended
December 31, 2004 on Wednesday, February 9, 2005 after the market closes. After
the release, the company will host a conference call to discuss these results.
The conference call will take place at 4:45 PM EST later that day. Interested
participants should call 888-874-9713 when calling within the United States or
973-935-8506 when calling internationally. There will be a playback available
as well. To listen to the playback, please call 877-519- 4471 when calling
within the United States or 973-341-3080 when calling internationally. Please
use pass code 5606173 for the replay.
This call is being webcast by ViaVid Broadcasting and can be accessed at eRT's
web site at http://www.ert.com/. The webcast may also be accessed at ViaVid's
website at: http://www.viavid.net/detailpage.aspx?sid=000021BA. The webcast can
be accessed until March 9, 2005 on either site.
Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/) is a
provider of technology and services to the pharmaceutical, biotechnology and
medical device industries on a global basis. The company is a market leader in
providing centralized core-diagnostic electrocardiographic (ECG) technology and
services to evaluate cardiac safety in clinical development. The company is
also a leader in providing technology and services to streamline the clinical
trials process by enabling its customers to automate the collection, analysis,
and distribution of clinical data in all phases of clinical development.
Statements included in this release may constitute forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995.
Such statements involve a number of risks and uncertainties such as competitive
factors, technological development, market demand, and the company's ability to
obtain new contracts and accurately estimate net revenues due to variability in
size, scope and duration of projects, and internal issues in the sponsoring
client. As a result, actual results may differ materially from any financial
outlooks stated herein. Further information on potential factors that could
affect the company's financial results can be found in the company's Reports on
Form 10-K and 10-Q filed with the Securities and Exchange Commission.
DATASOURCE: eResearchTechnology, Inc.
CONTACT: Joan Sterlacci of eResearchTechnology, Inc., +1-908-203-6473;
or Matt Hayden of Hayden Communications, +1-858-456-4533, for
eResearchTechnology
Web site: http://www.ert.com/